Dr. Bruce W. Porterfield
Overview
Bruce Porterfield is an Oncologist in Panama City, Florida. Dr. Porterfield is highly rated in 17 conditions, according to our data. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Congenital Antithrombin 3 Deficiency, Protein S Deficiency, and Protein C Deficiency. Dr. Porterfield is currently accepting new patients.
His clinical research consists of participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2100 State Ave, Panama City, FL 32405
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Florida Cancer Affilliates
Andrew Weber is an Oncologist in Panama City, Florida. Dr. Weber is highly rated in 96 conditions, according to our data. His top areas of expertise are Paget Disease of the Breast, Pleuropulmonary Blastoma, Lung Cancer, and Febrile Neutropenia. Dr. Weber is currently accepting new patients.
Florida Cancer Affilliates
Christopher Haberman is an Oncologist in Panama City, Florida. Dr. Haberman is highly rated in 56 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Neuroendocrine Tumor, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Haberman is currently accepting new patients.
Ascension Sacred Heart Medical Oncology Group Bay
Thomas Johnson is an Oncologist in Panama City, Florida. Dr. Johnson is highly rated in 39 conditions, according to our data. His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Lung Cancer.
Frequently Asked Questions about Dr. Bruce W. Porterfield
How do I make an appointment with Dr. Bruce W. Porterfield?
You can book an appointment with Dr. Bruce W. Porterfield by calling their office at 850-763-0036. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Bruce W. Porterfield a top-rated expert for Paroxysmal Nocturnal Hemoglobinuria (PNH)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bruce W. Porterfield is classified as an Distinguished expert for Paroxysmal Nocturnal Hemoglobinuria (PNH), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Bruce W. Porterfield specialize in?
While Dr. Bruce W. Porterfield is a Oncology, they have specific expertise in Paroxysmal Nocturnal Hemoglobinuria (PNH), Congenital Antithrombin 3 Deficiency, and Protein S Deficiency. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Bruce W. Porterfield accept my insurance?
Dr. Bruce W. Porterfield accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 850-763-0036 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Paroxysmal Nocturnal Hemoglobinuria (PNH)Dr. Porterfield isDistinguished. Learn about Paroxysmal Nocturnal Hemoglobinuria (PNH).
- Advanced
- Breast CancerDr. Porterfield isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Porterfield isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Chronic Myelomonocytic Leukemia (CMML)Dr. Porterfield isAdvanced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Congenital Antithrombin 3 DeficiencyDr. Porterfield isAdvanced. Learn about Congenital Antithrombin 3 Deficiency.
- Familial Colorectal CancerDr. Porterfield isAdvanced. Learn about Familial Colorectal Cancer.
- Hereditary Resistance to Anti-Vitamin KDr. Porterfield isAdvanced. Learn about Hereditary Resistance to Anti-Vitamin K.
- Experienced
- Acute Mountain SicknessDr. Porterfield isExperienced. Learn about Acute Mountain Sickness.
- Adrenal CancerDr. Porterfield isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Porterfield isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Soft Tissue SarcomaDr. Porterfield isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Porterfield isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Porterfield isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.